Cabaletta Bio CEO to Speak at Stifel 2024 Virtual Cell Therapy Forum

Cabaletta Bio

PHILADELPHIA, PACabaletta Bio, Inc. (Nasdaq: CABA) announced that Steven Nichtberger, M.D., its Chief Executive Officer, will participate in a fireside chat at the Stifel 2024 Virtual Cell Therapy Forum on Tuesday, July 9, 2024. The event will begin at 1:00 p.m. ET.

The forum, starting at 10:55 AM EDT, gathers experts and leaders in cell therapy to discuss industry advancements.

Cabaletta Bio specializes in developing engineered T cell therapies aimed at treating autoimmune diseases. The company focuses on creating treatments that could offer deep, durable, and potentially curative outcomes for patients.

The live webcast of Dr. Nichtberger’s presentation will be accessible via the News and Events section on Cabaletta Bio’s website. Replays will be available for 30 days post-event.

Attendees can expect insights into the latest developments in T cell therapies and their potential impacts on autoimmune disease treatment.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  LS Retail and FreedomPay Partner to Enhance Payment Solutions